A Longitudinal MRI Study of Brain Development in Fragile X Syndrome

脆性 X 综合征患者大脑发育的纵向 MRI 研究

基本信息

项目摘要

DESCRIPTION (provided by applicant): This application "A Longitudinal MRI Study of Brain Development in Fragile X Syndrome," is a proposal to conduct a longitudinal MRI study of very early brain and behavior development at 6, 12 and 24 months in infants with Fragile X Syndrome (FXS). This study will examine how the trajectory and growth of brain development in infants with FXS compares to early brain development in infants (at high-risk for autism) who later develop an autism spectrum disorder and in infants with typical brain development. Since many children with FXS also have an autism spectrum disorder (ASD), the design of this study will allow us to contrast brain development profiles in ASD children without FXS, as well as those FXS children who may also have an ASD. The high-risk autism subjects and typical controls are being collected as part of a funded Autism Centers of Excellence (ACE) Network entitled, "A Longitudinal MRI Study of Infants at Risk for Autism", currently in year 2. Three of the ACE Network sites will be participating in this project (two clinical data collection sites: UNC and Washington University, and a data coordinating site at Montreal Neurological Institute). Resources in this network, and available to this proposal, include expertise in imaging methods for infant brain and behavioral tools for detecting early (emerging) signs of autism. The final sample of FXS in this study will include 37 infants with FXS (with either 2 or 3 longitudinal scans each). For data analysis in this current proposal, the infants with FXS will be compared to the ACE dataset of 68 infants with ASD (without FXS), 163 infants at risk for ASD but considered ASD(-), and 66 TYP controls. Analysis will examine longitudinal MRI and behavioral data at 6, 12 and 24 months for these children. Preliminary data from our group suggests that the brain volume profiles of FXS and autistic children are significantly different at age 2. Individuals with FXS show a pattern of brain abnormalities at age 2 that differs from typical and developmentally-delayed (non-FXS) two year olds (with marked temporal lobe white matter enlargement, and ~40% caudate enlargement), and autistic two year olds with FXS differ strikingly from autistic non-FXS two year olds. By contrasting the early brain development of infants with FXS, we will be able to address several important hypotheses about the trajectory of early post- natal brain overgrowth (regions, tissues, structures and fiber tracts) in FXS, as measured on MRI and DTI, and its potential relationship to clinical features, particularly those features characteristic of and associated with ASD. This study has the potential to distinguish specific behavioral, genetic, and neurobiological features that characterize infants with FXS in comparison to infants at risk for autism without FXS and those with typical development. This proposal is a response to RFA PA-07-284 that requests submissions examining the interface of autism and Fragile X Syndrome. PUBLIC HEALTH RELEVANCE: "A Longitudinal MRI Study of Brain Development in Fragile X Syndrome," is a proposal to study very early brain and behavior development at 6, 12 and 24 months in infants with Fragile X Syndrome (FXS) using Magnetic Resonance Imaging (MRI) and Diffusion Tensor Imaging (DTI). We will examine how the trajectory and growth of brain development in infants with FXS compares to early brain development in infants at high-risk for autism (who later develop an autism spectrum disorder), as well as typical developing infants. We will address several important hypotheses about the trajectory of early post-natal brain overgrowth (regions, tissues, structures and fiber tracts) in FXS, as measured on MRI and DTI, and its potential relationship to clinical features, particularly those features characteristic of ASD. This study has the potential to distinguish specific behavioral, genetic, and neurobiological features that characterize infants with FXS in comparison with infants at high-risk for autism and those with typical development.
描述(由申请人提供):本申请“A Longitudinal MRI Study of Brain Development in Fragile X Syndrome”,是对脆性X综合征(FXS)婴儿在6、12和24个月的早期大脑和行为发育进行纵向MRI研究的建议。本研究将研究FXS婴儿的大脑发育轨迹和生长情况,与后来发展为自闭症谱系障碍的婴儿(自闭症高危人群)和典型大脑发育婴儿的早期大脑发育进行比较。由于许多患有FXS的儿童也患有自闭症谱系障碍(ASD),因此本研究的设计将使我们能够对比没有FXS的ASD儿童以及可能患有ASD的FXS儿童的大脑发育概况。高风险自闭症受试者和典型对照者正在被收集,作为资助的自闭症卓越中心(ACE)网络的一部分,题为“自闭症风险婴儿的纵向MRI研究”,目前已进入第2年。ACE网络的三个站点将参与该项目(两个临床数据收集站点:北卡罗来纳大学和华盛顿大学,以及蒙特利尔神经学研究所的数据协调站点)。这个网络中的资源,以及对这个提议可用的资源,包括婴儿大脑成像方法的专业知识和用于检测早期(新出现的)自闭症迹象的行为工具。本研究中FXS的最终样本将包括37名患有FXS的婴儿(每个婴儿进行2或3次纵向扫描)。在本研究的数据分析中,FXS患儿将与ACE数据集进行比较,ACE数据集包括68名ASD患儿(无FXS)、163名有ASD风险但被认为是ASD的患儿(-)和66名TYP对照。分析将检查这些儿童在6、12和24个月时的纵向MRI和行为数据。我们小组的初步数据表明,FXS和自闭症儿童在2岁时的脑容量谱有显著差异。患有FXS的个体在2岁时表现出与典型和发育迟缓(非FXS)两岁儿童(颞叶白质明显增大,尾状核增大约40%)不同的大脑异常模式,患有FXS的两岁自闭症儿童与患有非FXS的两岁自闭症儿童有着显著差异。通过对比FXS婴儿的早期大脑发育,我们将能够通过MRI和DTI测量FXS早期产后大脑过度生长(区域、组织、结构和纤维束)的轨迹,以及其与临床特征,特别是与ASD相关的特征的潜在关系,提出几个重要的假设。本研究有可能区分患有FXS的婴儿的特定行为、遗传和神经生物学特征,并将其与有自闭症风险的无FXS婴儿和发育正常的婴儿进行比较。该提案是对RFA PA-07-284的回应,RFA PA-07-284要求提交审查自闭症和脆性X综合征的界面。公共卫生相关性:“脆性X综合征大脑发育的纵向MRI研究”是一项使用磁共振成像(MRI)和弥散张量成像(DTI)研究脆性X综合征(FXS)婴儿6、12和24个月早期大脑和行为发育的建议。我们将研究FXS婴儿的大脑发育轨迹和生长情况与自闭症高危婴儿(后来发展为自闭症谱系障碍)以及典型发育婴儿的早期大脑发育进行比较。我们将探讨通过MRI和DTI测量的FXS早期产后大脑过度生长(区域、组织、结构和纤维束)轨迹的几个重要假设,以及其与临床特征,特别是ASD特征的潜在关系。本研究有可能区分FXS婴儿与自闭症高危婴儿和正常发育婴儿的特定行为、遗传和神经生物学特征。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Heather Cody Hazlett其他文献

Heather Cody Hazlett的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Heather Cody Hazlett', 18)}}的其他基金

White Matter Pathology in Angelman Syndrome and Its Potential as an Outcome Measure in Clinical Trials
安杰曼综合征的白质病理学及其作为临床试验结果衡量指标的潜力
  • 批准号:
    10174980
  • 财政年份:
    2018
  • 资助金额:
    $ 54.96万
  • 项目类别:
White Matter Pathology in Angelman Syndrome and Its Potential as an Outcome Measure in Clinical Trials
安杰曼综合征的白质病理学及其作为临床试验结果衡量指标的潜力
  • 批准号:
    9974549
  • 财政年份:
    2018
  • 资助金额:
    $ 54.96万
  • 项目类别:
White Matter Pathology in Angelman Syndrome and Its Potential as an Outcome Measure in Clinical Trials
安杰曼综合征的白质病理学及其作为临床试验结果衡量指标的潜力
  • 批准号:
    10436810
  • 财政年份:
    2018
  • 资助金额:
    $ 54.96万
  • 项目类别:
White Matter Fiber Tract Pathology in a Genetically-Defined Neurodevelopmental Disorder
遗传性神经发育障碍中的白质纤维束病理学
  • 批准号:
    9571423
  • 财政年份:
    2017
  • 资助金额:
    $ 54.96万
  • 项目类别:
A Longitudinal MRI Study of Brain Development in Fragile X Syndrome
脆性 X 综合征患者大脑发育的纵向 MRI 研究
  • 批准号:
    8243366
  • 财政年份:
    2009
  • 资助金额:
    $ 54.96万
  • 项目类别:
A Longitudinal MRI Study of Brain Development in Fragile X Syndrome
脆性 X 综合征患者大脑发育的纵向 MRI 研究
  • 批准号:
    8722578
  • 财政年份:
    2009
  • 资助金额:
    $ 54.96万
  • 项目类别:
A Longitudinal MRI Study of Brain Development in Fragile X Syndrome
脆性 X 综合征患者大脑发育的纵向 MRI 研究
  • 批准号:
    7736760
  • 财政年份:
    2009
  • 资助金额:
    $ 54.96万
  • 项目类别:
A Longitudinal MRI Study of Brain Development in Fragile X Syndrome
脆性 X 综合征患者大脑发育的纵向 MRI 研究
  • 批准号:
    7944032
  • 财政年份:
    2009
  • 资助金额:
    $ 54.96万
  • 项目类别:
STRUCTURAL AND FUNCTIONAL CONNECTIVITY IN SCHIZOPHRENIA IN NEUROPSYCHIATRIC DISOR
神经精神疾病中精神分裂症的结构和功能连接
  • 批准号:
    7669320
  • 财政年份:
    2008
  • 资助金额:
    $ 54.96万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 54.96万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 54.96万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 54.96万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 54.96万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 54.96万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 54.96万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 54.96万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 54.96万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 54.96万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 54.96万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了